Skip to product information
1 of 1

Elabscience

SKU:PKSH032188

Recombinant Human CCL16 Protein

Recombinant Human CCL16 Protein

Regular price $200.00 USD
Regular price Sale price $200.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
Introducing the Recombinant Human CCL16 Protein, a cutting-edge biotechnological advancement in the field of protein synthesis. This meticulously engineered product is a result of extensive research and development, aimed at providing a high-quality and reliable solution for various scientific applications.

The Recombinant Human CCL16 Protein is produced using state-of-the-art recombinant DNA technology, ensuring utmost purity and consistency. With its exceptional bioactivity, this protein serves as a valuable tool for researchers and scientists in the study of chemotaxis, inflammation, and immune responses.

This protein is meticulously manufactured under stringent quality control measures, guaranteeing its superior performance and reproducibility. Its high stability and long shelf life make it an ideal choice for laboratory experiments and industrial applications alike.

The Recombinant Human CCL16 Protein is supplied in a convenient lyophilized form, allowing for easy storage and reconstitution. Its user-friendly nature enables seamless integration into various experimental protocols, facilitating efficient and accurate results.

Furthermore, this product adheres to the highest ethical standards, as it is produced using recombinant technology, eliminating the need for animal-derived sources. This not only ensures the absence of contaminants but also promotes sustainability and environmental consciousness.

In summary, the Recombinant Human CCL16 Protein is a groundbreaking scientific tool that offers unparalleled quality, reliability, and versatility. Its exceptional purity, stability, and bioactivity make it an indispensable asset for researchers and scientists in their pursuit of advancing knowledge and understanding in the fields of chemotaxis, inflammation, and immune responses.
View full details